Neoadjuvant phase II trial of chemo-radiotherapy (CRT) in patients with resectable (R) and borderline resectable (BR) pancreatic ductal adenocarcinoma (PDA)

被引：1
|
作者：
Damarla, V. [1 ]
Dobrosotskaya, D. [1 ]
Siddiqui, F. [2 ]
Wollner, I. [1 ]
Raoufi, M. [4 ]
Li, J. [5 ]
Kwon, D. [3 ]
Khan, G. [1 ]
机构：
[1] Henry Ford Hlth Syst, Dept Med Oncol, Detroit, MI USA
[2] Henry Ford Hlth Syst, Dept Radiat Oncol, Detroit, MI USA
[3] Henry Ford Hlth Syst, Dept Surg Oncol, Detroit, MI USA
[4] Henry Ford Hlth Syst, Dept Pathol, Detroit, MI USA
[5] Henry Ford Hlth Syst, Dept Biostat, Detroit, MI USA
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 92卷
关键词：
D O I：
10.1016/j.ejca.2018.01.110
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P11
引用
收藏
页码：S8 / S9
页数：2
相关论文
共 50 条
  • [41] Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
    Qiancheng Hu
    Dan Wang
    Ye Chen
    Xiaofen Li
    Peng Cao
    Dan Cao
    Radiation Oncology, 14
  • [42] Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic ductal adenocarcinoma in a high volume referral centre
    Itchins, M.
    Arena, J.
    Nahm, C. B.
    Rabindran, J.
    Kim, S.
    Gibbs, E.
    Bergamin, S.
    Chua, T. C.
    Gill, A. J.
    Maher, R.
    Diakos, C.
    Wong, M.
    Mittal, A.
    Hruby, G.
    Kneebone, A.
    Pavlakis, N.
    Samra, J.
    Clarke, S.
    EJSO, 2017, 43 (09): : 1711 - 1717
  • [43] Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population
    Walpole, Imogen
    Lee, Belinda
    Shapiro, Jeremy
    Thomson, Benjamin
    Lipton, Lara
    Ananda, Sumitra
    Usatoff, Val
    Mclachlan, Sue-Ann
    Knowles, Brett
    Fox, Adrian
    Wong, Rachel
    Cooray, Prasad
    Burge, Matthew
    Clarke, Kate
    Pattison, Sharon
    Nikfarjam, Mehrdad
    Tebbutt, Niall
    Harris, Marion
    Nagrial, Adnan
    Zielinski, Rob
    Chee, Cheng Ean
    Gibbs, Peter
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (01) : 214 - 225
  • [44] Use and Outcomes from Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Ductal Adenocarcinoma in an Australasian Population
    Lee, Belinda
    Walpole, Imogen
    Shapiro, Julia
    Thomson, Benjamin
    Lipton, Lara
    Ananda, Sumitra
    Usatoff, Val
    Mclachlan, Sue-Anne
    Knowles, Brett
    Fox, Adrian
    Wong, Rachel
    Cooray, Prasad
    Burge, Matthew
    Clarke, Kate
    Pattison, Sharon
    Nikfarjam, Mehrdad
    Tebbutt, Niall
    Harris, Marion
    Nagrial, Adnan
    Zielinski, Rob
    Chee, Cheng Ean
    Gibbs, Peter
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 175 - 175
  • [45] Prognostic Factors in Patients With Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Resection
    Ren, Weizheng
    Xourafas, Dimitrios
    Ashley, Stanley W.
    Clancy, Thomas E.
    AMERICAN SURGEON, 2022, 88 (06) : 1172 - 1180
  • [46] A Phase II Trial of Neoadjuvant S-1 Therapy in Patients With Resectable Pancreatic Adenocarcinoma: HOPS-R01
    Nakamura, T.
    Kawakami, H.
    Takahashi, K.
    Kimura, Y.
    Hayashi, T.
    Ishiwatari, H.
    Motoya, M.
    Goto, T.
    Yamakita, K.
    Sakuhara, Y.
    Maguchi, H.
    Hirano, S.
    PANCREAS, 2019, 48 (10) : 1496 - 1496
  • [47] Intraoperative Radiotherapy after Neoadjuvant Chemotherapy and Radiotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma: A Single-Institution Analysis
    Sadek, Kareem
    Tice, Mary P.
    Poruk, Katherine E.
    Stauffer, John A.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S283 - S284
  • [48] A simple risk score for detecting radiological occult metastasis in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma
    Sakaguchi, Tatsuma
    Satoi, Sohei
    Hashimoto, Daisuke
    Yamamoto, Tomohisa
    Yamaki, So
    Hirooka, Satoshi
    Ishida, Mitsuaki
    Ikeura, Tsukasa
    Inoue, Kentaro
    Sekimoto, Mitsugu
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2022, 29 (02) : 262 - 270
  • [49] Chemotherapy for patients with non-resectable pancreatic cancer with additional chemo-radiotherapy for patients with potentially resectable tumours: Final results
    Pfeiffer, P.
    Ladekarl, M.
    Mortensen, M. B.
    Fromm, A-L.
    Bjerregaard, J. K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] Dose Dense Paclitaxel and Carboplatin as Neoadjuvant Therapy for Resectable/Borderline Resectable NSCLC - A Phase II Trial
    Mittal, A.
    Malik, P.
    Kumar, S.
    Jain, D.
    Pathy, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S630 - S630
12345